·ipamorelin

How to reconstitute Ipamorelin — visual step-by-step

A visual, step-by-step reconstitution protocol for Ipamorelin growth hormone secretagogue research vials — with dose math for research protocols and refrigerated storage guidelines. For research purposes only.

By Pepticker Editorial, Pepticker editorial teamEducational overview · not yet clinician-reviewed
Awaiting medical review
[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop
[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

What is reconstitution and why it matters for Ipamorelin

Ipamorelin is a synthetic pentapeptide (5-amino-acid) selective growth hormone secretagogue. Unlike GHRP-6 or GHRP-2, ipamorelin does not significantly stimulate cortisol or prolactin release, making it a highly selective GH research compound. Research vials ship as white lyophilized powder, typically 2–5 mg. As a short, unmodified peptide, ipamorelin reconstitutes readily and is relatively stable in solution. Reconstitution accuracy is critical because many research protocols involve multiple daily injections, and errors in concentration compound across injections.

Internal links: see the Ipamorelin peptide profile at /peptides/ipamorelin, the ipamorelin research overview guide, and /methodology.

Materials required

Gather: (1) Ipamorelin research vial — commonly 2 mg or 5 mg lyophilized powder. (2) Bacteriostatic water for injection, 30 mL multi-dose vial. (3) Two 1 mL U-100 insulin syringes. (4) Two 70% IPA alcohol swabs. (5) Clean, flat workspace. (6) Sharps disposal container. (7) Permanent marker and adhesive label.

Step-by-step reconstitution protocol

Step 1 — Verify materials (see Diagram 1)

Inspect the ipamorelin vial for white lyophilized powder. Inspect the BAC water vial for clarity and confirm within its use-by date. Wash hands for 20 seconds.

Step 2 — Swab both septa

Swab the BAC water septum with 70% IPA in a single outward stroke. Allow 10–15 seconds to air-dry. Repeat with a fresh swab on the ipamorelin vial. Do not touch the swabbed surfaces.

Step 3 — Draw bacteriostatic water (see Diagram 2)

Insert a fresh needle into the BAC water vial and invert. For a 2 mg ipamorelin vial: 1.0 mL gives 2,000 mcg/mL; 2.0 mL gives 1,000 mcg/mL. For a 5 mg vial: 1.0 mL gives 5,000 mcg/mL; 2.0 mL gives 2,500 mcg/mL. For per-injection research doses in the 100–300 mcg range, a 1,000 mcg/mL concentration from a 2 mg vial is practical: 100 mcg = 10 units, 200 mcg = 20 units, 300 mcg = 30 units.

Step 4 — Introduce water against the glass wall (see Diagram 3)

Tilt the ipamorelin vial at 45 degrees. Insert the needle through the septum, directing the tip at the inner glass wall. Slowly release the bacteriostatic water down the wall. Ipamorelin is a short peptide and dissolves easily, but wall-directed introduction is best practice to minimize foam and turbulence.

Step 5 — Gently swirl to dissolve

Roll the vial between your palms for 10–20 seconds. Ipamorelin is a short pentapeptide and should dissolve completely and quickly into a clear, colorless solution. Do not shake.

Step 6 — Label and store (see Diagram 4)

Label with peptide name, concentration, reconstitution date, and 28-day expiry. Refrigerate at 2–8°C. Do not freeze. For multi-injection daily protocols, refrigerated ipamorelin in BAC water maintains sterility and potency across the 28-day use window.

Dose math: translating research doses to U-100 syringe units

Example — 2 mg vial in 2.0 mL BAC water: 1,000 mcg/mL = 10 mcg per unit on U-100. A 100 mcg dose = 10 units. A 200 mcg dose = 20 units. A 300 mcg dose = 30 units. Example — 5 mg vial in 2.0 mL BAC water: 2,500 mcg/mL = 25 mcg per unit. A 100 mcg dose = 4 units (small draw — consider a more dilute reconstitution for accuracy). A 200 mcg dose = 8 units. For repeated daily injections, the 1,000 mcg/mL concentration is easier to measure reproducibly with a U-100 syringe.

Storage post-reconstitution

Reconstituted ipamorelin in bacteriostatic water: refrigerate at 2–8°C for up to 28 days. Protect from light. Do not freeze. Ipamorelin’s short pentapeptide structure is stable in aqueous solution with benzyl alcohol preservative.

Common mistakes to avoid

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Frequently asked questions

Frequently asked
Why is ipamorelin considered more selective than other GHRPs?
Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a synthetic pentapeptide that stimulates GH release through the ghrelin/GHS-R1a receptor with minimal off-target effects on cortisol, prolactin, or ACTH. Raun et al. (1998) demonstrated this selectivity profile in rat studies, making ipamorelin the first ghrelin receptor agonist characterized as highly selective for GH secretion without concurrent stress-hormone stimulation.
What concentration is best for ipamorelin research protocols involving 100–300 mcg doses?
For doses in the 100–300 mcg range, a concentration of 1,000 mcg/mL (1 mg/mL) is recommended. This places the dose draw at 10–30 units on a U-100 syringe — a comfortable and measurable range. At higher concentrations (5,000 mcg/mL), a 100 mcg dose would require only 2 units, which is too small for accurate measurement with a standard U-100 syringe.
How long does reconstituted ipamorelin remain stable?
Reconstituted ipamorelin in bacteriostatic water, refrigerated at 2–8°C, is generally stable for up to 28 days. Ipamorelin’s pentapeptide structure is relatively stable in aqueous solution with benzyl alcohol as preservative. Lyophilized ipamorelin stored at -20°C can remain stable for 12–24 months.
Can ipamorelin be combined with other peptides (e.g., CJC-1295) in the same syringe?
Combining peptides in a single syringe (peptide stacking) is a protocol design decision that depends on the specific research objectives, compatibility data, and ethical/regulatory review. For research reporting purposes, each peptide should be reconstituted separately and drawn into the syringe immediately before use if combining. There are no published stability data for ipamorelin+CJC-1295 combination solutions; researchers must assess this independently.
Citations
  1. Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/
  2. USP <797> Pharmaceutical Compounding — Sterile Preparations. https://www.usp.org/compounding/general-chapter-797
  3. FDA — Bacteriostatic Water for Injection USP prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/016831Orig1s040lbl.pdf

Was this guide helpful?